logo

For the Inventor, By the Inventor

Gainesville, FL, United States of America

Steven Albert Benner

USPTO Granted Patents = 57 


Average Co-Inventor Count = 1.4

ph-index = 13

Forward Citations = 658(Granted Patents)

Forward Citations (Not Self Cited) = 622(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Pasadena, CA (US) (1999)
  • Gainesvillle, FL (US) (2002)
  • Gainsville, FL (US) (2015)
  • Gainesville, FL (US) (1999 - 2023)

Company Filing History:

goldMedal1 out of 11 
 
Eragen Biosciences, Inc.
 patents
silverMedal55 out of 832,912 
Other
 patents
where one patent can have more than one assignee

Years Active: 1999-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Ribonucleoside Derivatives
Information Storage
Directed Transliteration
Nucleoside Triphosphates
Molecular Recognition Systems
Amplification of Oligonucleotides
Non-Standard Nucleotides
Recombinase-Based Amplification
Polymerase Chain Reactions
Expanded Genetic Alphabets
Nucleotide Analogs
DNA Synthesis
57 patents (USPTO):Explore Patents
1. 11850258 - Ribonucleoside derivatives with 3′-aminoxy groups (2023-12-26),
2. 11708389 - Information storage with rectified dna (2023-07-25),
3. 11667943 - Directed transliteration of nucleotides in DNA (2023-06-06),
4. 11667942 - Assembly of long DNA molecules by transliteration (2023-06-06),
5. 11168106 - Synthesis and stabilization of nicotinamide ribose and its derivatives (2021-11-09),
6. 11117922 - Processes using nucleoside triphosphates with stable aminoxy groups (2021-09-14),
7. 11034964 - Binding molecules built from L-DNA with added nucleotides (2021-06-15),
8. 10934569 - Enzymatic processes for synthesizing RNA containing certain non-standard nucleotides (2021-03-02),
9. 10920267 - Isothermal amplification of oligonucleotides (2021-02-16),
10. 10865431 - Polymerase incorporation of non-standard nucleotides (2020-12-15),
11. 10829812 - Amplification of oligonucleotides containing non-standard nucleotides (2020-11-10),
12. 10829511 - Molecular recognition systems with pyrimidine analog pairing (2020-11-10),
13. 10745728 - Applications for biversal nucleoside analogs (2020-08-18),
14. 10654841 - Processes with terminal transferase, aminoxy nucleoside triphosphates, and nucleobase analogs (2020-05-19),
15. 10513704 - Binding and catalytic molecules built from L-DNA with added nucleotides (2019-12-24),

Title: Steven Albert Benner: A Pioneer in DNA Innovations

Introduction: Steven Albert Benner, based in Gainesville, FL, is a renowned inventor who has made significant contributions to the field of genetic research and information storage. Holding an impressive 56 patents, his work focuses on advancing our understanding and application of DNA structures and their potential uses in technology.

Latest Patents: Among his latest innovations is the patent for "Information Storage with Rectified DNA." This invention introduces compositions of matter that utilize DNA analogues, replacing traditional components with alternatives that address common issues encountered during the synthesis and functioning of these compounds. Another notable patent is "Directed Transliteration of Nucleotides in DNA," which describes PCR processes that efficiently convert targeted duplex DNA molecules with eight different nucleotide building blocks into DNA structured from only four nucleotides.

Career Highlights: Steven has held pivotal roles in several research institutions and companies, driving forward-thinking research that merges biology with practical applications. Notably, he has worked with Eragen Biosciences, Inc., where his expertise has been instrumental in fostering innovative research and developments.

Collaborations: Throughout his career, Steven has collaborated with talented individuals such as Zunyi Yang and Nicole Aurora Leal. These partnerships have enriched his projects and contributed to the success of various research initiatives.

Conclusion: Steven Albert Benner stands out as a key figure in the innovation landscape of DNA research and application. His extensive portfolio of patents showcases his commitment to solving complex challenges in the field, paving the way for future advancements in biotechnological applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…